Three new board members for Bacterin
This article was originally published in Clinica
Bioactive coating specialist Bacterin International has appointed three "seasoned financial experts" to its board of directors: Daniel Frank, Gary Simon and Ken Calligar. Mr Frank has 31 years of asset management experience with a focus on the healthcare industry. He has served on several company boards including stent developer Reva Medical and point-of-care testing firm i-STAT. Mr Simon is currently a manager of UVE Partners, an investment fund that he co-founded. Before this, he was senior vice-president of investment banking firm Barington Capital Group. Mr Calligar is the founder and managing partner of investment banking firm Convertible Capital, and was previously a managing director of Jefferies & Co. He has over 25 years' experience in the financial industry. Belgrade, Montana-based Bacterin develops coatings for medical devices, transplants and tissue products.